共 25 条
- [12] Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial Osteoporosis International, 2016, 27 : 309 - 318
- [15] Effects of novel cathepsin K inhibitor ONO-5334 on bone resorption markers: a study of four sustained release formulations with different pharmacokinetic patterns Journal of Bone and Mineral Metabolism, 2014, 32 : 447 - 454
- [16] Pharmacodynamic Effects on Biochemical Markers of Bone Turnover and Pharmacokinetics of the Cathepsin K Inhibitor, ONO-5334, in an Ascending Multiple-Dose, Phase 1 Study JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (03): : 306 - 318
- [17] Modeling and Simulation of Bone Mineral Density Response From a Phase 2 Study of ONO-5334, a New Cathepsin K Inhibitor, to Support Dose Selection in Osteoporosis JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (08): : 937 - 948